Literature DB >> 13218163

Ergotoxine inhibition of deciduoma formation and its reversal by progesterone.

M C SHELESNYAK.   

Abstract

Entities:  

Keywords:  ERGOT ALKALOIDS/effects; PROGESTERONE/effects; UTERUS/neoplasms

Mesh:

Substances:

Year:  1954        PMID: 13218163     DOI: 10.1152/ajplegacy.1954.179.2.301

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


× No keyword cloud information.
  4 in total

1.  Effects of 2-Br- -ergocryptine on plasma prolactin level and milk yield in cows.

Authors:  H Karg; D Schams; V Reinhardt
Journal:  Experientia       Date:  1972-05-15

Review 2.  Therapeutic applications of bromocriptine in endocrine and neurological diseases.

Authors:  K Y Ho; M O Thorner
Journal:  Drugs       Date:  1988-07       Impact factor: 9.546

3.  The 'Alice in Wonderland' experience. Ergot alkaloid therapy for prolactin-secreting pituitary tumors.

Authors:  R C Williams; C Sherman; M T Buckman
Journal:  West J Med       Date:  1983-03

Review 4.  The endocrine profile of bromocriptine: its application in endocrine diseases.

Authors:  I Lancranjan
Journal:  J Neural Transm       Date:  1981       Impact factor: 3.575

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.